Vanguard Group’s TScan Therapeutics TCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.12M | Sell |
|
|||||
|
2025
Q1 | $3.25M | Sell |
|
|||||
|
2024
Q4 | $7.24M | Buy |
|
|||||
|
2024
Q3 | $11.7M | Buy |
|
|||||
|
2024
Q2 | $12.5M | Buy |
|
|||||
|
2024
Q1 | $14.4M | Buy |
|
|||||
|
2023
Q4 | $10.4M | Buy |
|
|||||
|
2023
Q3 | $4.49M | Buy |
|
|||||
|
2023
Q2 | $3.4M | Buy |
|
|||||
|
2023
Q1 | $623K | Buy |
|
|||||
|
2022
Q4 | $412K | Buy |
|
|||||
|
2022
Q3 | $785K | Buy |
|
|||||
|
2022
Q2 | $711K | Sell |
|
|||||
|
2022
Q1 | $636K | Sell |
|
|||||
|
2021
Q4 | $1.07M | Sell |
|
|||||
|
2021
Q3 | $3.71M | Buy |
|